| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* CEDIE-Endocrinology, Htal. de Niños ``R. Gutiérrez,'' Buenos Aires, Argentina;
Department of Physiology and Pharmacology, University of Pernambuco, Recife,Brazil
We studied the ability of ATP to inhibit in vitro the degrading activity of insulin-degrading enzyme. The enzyme was purified from rat skeletal muscle by successive chromatographic steps. The last purification step showed two bands at 110 and 60 kDa in polyacrylamide gel. The enzyme was characterized by its insulin degradation activity, the substrate competition of unlabeled to labeled insulin, the profile of enzyme inhibitors, and the recognition by a specific antibody. One to 5 mM ATP induced a dose-dependent inhibition of insulin degradation (determined by trichloroacetic acid precipitation and insulin antibody binding). Inhibition by 3 mM adenosine 5'-diphosphate, adenosine 5'-monophosphate, guanosine 5'-triphosphate, pyrophosphate, ß-
-methyleneadenosine 5'-triphosphate, adenosine 5'-O-(3 thiotriphosphate), and dibutiryl cyclic adenosine 5'-monophosphate was 74%, 4%, 38%, 46%, 65%, 36%, and 0%, respectively, of that produced by 3 mM ATP. Kinetic analysis of ATP inhibition suggested an allosteric effect as the plot of 1/v (insulin degradation) versus ATP concentration was not linear and the Hill coefficient was more than 1 (1.51 and 2.44). The binding constant for allosteric inhibition was KiT = 1.5 x 10-7 M showing a decrease of enzyme affinity induced by ATP. We conclude that ATP has an inhibitory effect on the insulin degradation activity of the enzyme.
Key Words: insulin degradation • ATP inhibition • insulin-degrading activity
This article has been cited by other articles:
|
|
 |
|
  H. Im, M. Manolopoulou, E. Malito, Y. Shen, J. Zhao, M. Neant-Fery, C.-Y. Sun, S. C. Meredith, S. S. Sisodia, M. A. Leissring, et al. Structure of Substrate-free Human Insulin-degrading Enzyme (IDE) and Biophysical Analysis of ATP-induced Conformational Switch of IDE J. Biol. Chem., August 31, 2007; 282(35): 25453 - 25463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. del Carmen Camberos and J. C. Cresto Insulin-Degrading Enzyme Hydrolyzes ATP Experimental Biology and Medicine, February 1, 2007; 232(2): 281 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Song, M. A. Juliano, L. Juliano, M. G. Fried, S. L. Wagner, and L. B. Hersh ATP Effects on Insulin-degrading Enzyme Are Mediated Primarily through Its Triphosphate Moiety J. Biol. Chem., December 24, 2004; 279(52): 54216 - 54220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.-S. Song, M. A. Juliano, L. Juliano, and L. B. Hersh Substrate Activation of Insulin-degrading Enzyme (Insulysin): A POTENTIAL TARGET FOR DRUG DEVELOPMENT J. Biol. Chem., December 12, 2003; 278(50): 49789 - 49794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Valera Mora, A. Scarfone, M. Calvani, A. V. Greco, and G. Mingrone Insulin Clearance in Obesity J. Am. Coll. Nutr., December 1, 2003; 22(6): 487 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. G. Hamel, J. L. Upward, and R. G. Bennett In Vitro Inhibition of Insulin-Degrading Enzyme by Long-Chain Fatty Acids and Their Coenzyme A Thioesters Endocrinology, June 1, 2003; 144(6): 2404 - 2408. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
